Business & regional news

Month Year

Email alerts

Sep 22, 2025

Groundbreaking study published in the Journal of the American Medical Association (JAMA) Neurology demonstrates effectiveness of Medtronic BrainSense™ Adaptive deep brain stimulation for people with Parkinson’s

The pivotal Medtronic Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) trial demonstrates global clinical effectiveness, long-term safety, and patient preference
- Neuromodulation
Jun 4, 2025

Medtronic receives FDA 510(k) clearance for Visualase™ V2 MRI-Guided Laser Ablation System

Minimally invasive laser technology now with enhanced capital system improvements, offering new user interface, workflow efficiencies, and upgrade capabilities
- Neuromodulation
Jan 23, 2025

New 12-month clinical data highlights significant and sustained benefits of the Inceptiv™ closed-loop spinal cord stimulation system

Study shows 67% mean reduction in Low-back Visual Analog Scale (VAS) pain score at 12 months; 87% of subjects had meaningful improvements in three or more quality of life (QoL) domains

Data to be presented at the North American Neuromodulation Society (NANS) Annual Meeting 2025; In all, Medtronic to highlight 22 poster and oral scientific data presentations
- Neuromodulation
Sep 24, 2024

Medtronic to showcase real-world application of exclusive BrainSense™ technology and groundbreaking DBS research at the 2024 International Congress of Parkinson’s Disease and Movement Disorders®
- Neuromodulation
Sep 17, 2024

Medtronic pioneering ADAPT-PD clinical trial methods manuscript published, setting new standards in Parkinson's disease research

ADAPT-PD trial methods and preliminary data published in npj Parkinson’s disease
- Neuromodulation

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa